Press Announcements > FDA permits marketing of device to treat diabetic foot ulcers

Press Announcements > FDA permits marketing of device to treat diabetic foot ulcers



FDA permits marketing of device to treat diabetic foot ulcers



Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. Continue reading.